New understanding of roundworm reproduction could have impact on human and animal infertility issues, say UAB scientists.
February 13, 2014

Sex cells

You might know that sex sells, but did you know that the sex of cells is important in biomedical research?
Published in Faculty Excellence
Through a UAB professor’s crowdsourcing efforts, volunteers are able to provide textbooks to visually impaired children in Bangladesh.
Published in Faculty Excellence

Pritchett has served the UAHSF as general counsel and corporate secretary for 20 years.

Published in Focus on Patient Care

Studies in recent years had suggested that cilia regulate vital processes including growth, appetite, mood, healing and vision.

The competition is designed to encourage students to conduct original research and to be reviewed by their peers.

Published in Student Experience

A study in mice with genetic mutations seen in human Alzheimer's disease found that the feeling of hunger itself may protect against the disease.

Professor says he has never had an intro-level sudent answer every question correctly for an entire semester.

Published in Student Experience

Gearing up to start an exercise program — especially for those over 40 — can be filled with pitfalls. Experts at UAB say start slow and low.

Published in Focus on Patient Care

Bradley Yoder, Ph.D., was among the authors of the article in Nature Medicine.

Undergraduate researcher given top honors from College of Arts and Sciences.

Published in Student Experience

Research suggests that a class of drugs for rheumatoid arthritis seeking approval this year could be effective against other autoimmune diseases.

Two UAB departments unite to become integrated research team.
Quirky evolution yields clues to a fatal condition.
Published in Focus on Patient Care
Kathleen Berecek, Ph.D., has been named professor emerita of physiology and biophysics in the UAB School of Medicine and School of Dentistry.
Published in Faculty Excellence

New research from UAB shows definitive link between a protein and cell activation; shutting both down could be a target of new treatments for cancer and autoimmune diseases.

Tigatuzumab, developed at UAB with Daiichi-Sankyo, targets aggressive, hard-to-treat tumors that make up 25 percent of all breast cancers

Published in Focus on Patient Care
Back to Top